 HighTower Advisors LLC purchased a new position in shares of Arena Pharmaceuticals, Inc. NASDAQ:ARNA in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 19,198 shares of the biopharmaceutical companys stock, valued at approximately 806,000. A number of other institutional investors and hedge funds ... 